ReviewClinical drug investigation2017
Nusinersen: The First Option Beyond Supportive Care for Spinal Muscular Atrophy.
Vikas Maharshi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it
ReviewClinical drug investigation2017
Vikas Maharshi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.